Interferon-α Resistance Associated Genes in Renal Cell Carcinoma Identified by Expression Profiling

Journal of Urology

Volumn 177, Issue 4, 2007, Pages 1264-1268

  Korkola, James E ^a   Kondagunta, G Varuni ^a   Reuter, Victor E ^a   Motzer, Robert J ^a   Chaganti, R S K ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

carcinoma; gene expression profiling; genes; interferon alpha; renal cell; tumor suppressor

Indexed keywords

PEGINTERFERON ALPHA2B; VON HIPPEL LINDAU PROTEIN;

ABCD3 GENE; ARTICLE; CHROMOSOME 4Q; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; GENE; GENE EXPRESSION PROFILING; GENE ISOLATION; GENE MAPPING; GENETIC ASSOCIATION; HS 11325 GENE; HS 76704 GENE; HS 94122 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; PHARMACOGENETICS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT RESPONSE; TUMOR SUPPRESSOR GENE; VHL GENE;

CARCINOMA, RENAL CELL; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION PROFILING; HUMANS; INTERFERON-ALPHA; KIDNEY NEOPLASMS;

EID: 33947217842     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.11.087     Document Type: Article

References (20)

1. Linehan W.M., and Zbar B. Focus on kidney cancer. Cancer Cell 6 (2004) 223
2. Motzer R.J., Bander N.H., and Nanus D.M. Renal-cell carcinoma. N Engl J Med 335 (1996) 865
3. Patel P.H., Chaganti R.S., and Motzer R.J. Targeted therapy for metastatic renal cell carcinoma. Br J Cancer 94 (2006) 614
4. Motzer R.J., Rini B.I., Bukowski R.M., Curti B.D., George D.J., Hudes G.R., et al. Sunitinib in patients with metastatic renal cell carcinoma. JAMA 295 (2006) 2516
5. Motzer R.J., Rakhit A., Ginsberg M., Rittweger K., Vuky J., Yu R., et al. Phase I trial of 40-kd branched pegylated interferon alfa-2a for patients with advanced renal cell carcinoma. J Clin Oncol 19 (2001) 1312
6. Bukowski R.M., Tendler C., Cutler D., Rose E., Laughlin M.M., and Statkevich P. Treating cancer with PEG Intron: pharmacokinetic profile and dosing guidelines for an improved interferon-alpha-2b formulation. Cancer 95 (2002) 389
7. Caraglia M., Marra M., Pelaia G., Maselli R., Caputi M., Marsico S.A., et al. Alpha-interferon and its effects on signal transduction pathways. J Cell Physiol 202 (2005) 323
8. Leaman D.W., Chawla-Sarkar M., Jacobs B., Vyas K., Sun Y., Ozdemir A., et al. Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-beta compared with IFN-alpha2. J Interferon Cytokine Res 23 (2003) 745
9. Zimmer R., and Thomas P. Expression profiling and interferon-beta regulation of liver metastases in colorectal cancer cells. Clin Exp Metastasis 19 (2002) 541
10. Korkola J.E., Houldsworth J., Dobrzynski D., Olshen A.B., Reuter V.E., Bosl G.J., et al. Gene expression-based classification of nonseminomatous male germ cell tumors. Oncogene 24 (2005) 5101
11. Tusher V.G., Tibshirani R., and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98 (2001) 5116
12. Gentleman R.C., Carey V.J., Bates D.M., Bolstad B., Dettling M., Dudoit S., et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5 (2004) R80
13. Maina E.N., Morris M.R., Zatyka M., Raval R.R., Banks R.E., Richards F.M., et al. Identification of novel VHL target genes and relationship to hypoxic response pathways. Oncogene 24 (2005) 4549
14. Zatyka M., daSilva N.F., Clifford S.C., Morris M.R., Wiesener M.S., Eckardt K.U., et al. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease. Cancer Res 62 (2002) 3803
15. Houshmand P., and Zlotnik A. Targeting tumor cells. Curr Opin Cell Biol 15 (2003) 640
16. Pritchard K.I., Shepherd L.E., O'Malley F.P., Andrulis I.L., Tu D., Bramwell V.H., et al. HER2 and responsiveness of breast cancer to adjuvant chemotherapy. N Engl J Med 354 (2006) 2103
17. Jiang F., Desper R., Papadimitriou C.H., Schaffer A.A., Kallioniemi O.P., Richter J., et al. Construction of evolutionary tree models for renal cell carcinoma from comparative genomic hybridization data. Cancer Res 60 (2000) 6503
18. Sanjmyatav J., Schubert J., and Junker K. Comparative study of renal cell carcinoma by CGH, multicolor-FISH and conventional cytogenic banding analysis. Oncol Rep 14 (2005) 1183
19. Moch H., Presti Jr. J.C., Sauter G., Buchholz N., Jordan P., Mihatsch M.J., et al. Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. Cancer Res 56 (1996) 27
20. Yasui K., Mihara S., Zhao C., Okamoto H., Saito-Ohara F., Tomida A., et al. Alteration in copy numbers of genes as a mechanism for acquired drug resistance. Cancer Res 64 (2004) 1403